Participation of molecular iodine and PPARG in prostate cancer progression and neuroendocrine differentiation

被引：0
作者：
Montes de Oca, Carlos
Alvarez, Lourdes
Aceves, Carmen
Anguiano, Brenda
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3394
引用
收藏
页数：2
相关论文
共 50 条
[21]   The spectrum of neuroendocrine differentiation in prostate cancer [J].
Siyuan Cheng ;
Xiuping Yu .
Prostate Cancer and Prostatic Diseases, 2021, 24 :1214-1215
[22]   Neuroendocrine differentiation in prostate cancer and development [J].
Sanders, Danielle N. ;
Grabowska, Magdalena ;
Matusik, Robert .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
[23]   The spectrum of neuroendocrine differentiation in prostate cancer [J].
Cheng, Siyuan ;
Yu, Xiuping .
PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) :1214-1215
[24]   Neuroendocrine differentiation of prostate cancer: a review [J].
Parimi, Vamsi ;
Goyal, Rajen ;
Poropatich, Kate ;
Yang, Ximing J. .
AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2014, 2 (04) :273-285
[25]   Neuroendocrine differentiation in the precursors of prostate cancer [J].
diSantAgnese, PA .
EUROPEAN UROLOGY, 1996, 30 (02) :185-190
[26]   HOXB13 EXPRESSION AND ITS ROLE IN PROSTATE CANCER PROGRESSION AND NEUROENDOCRINE DIFFERENTIATION [J].
Faisal, Farzana ;
Alshalalfa, Mohammed ;
Davicioni, Elai ;
Karnes, R. Jeffrey ;
Isaacs, William ;
Lotan, Tamara ;
Schaeffer, Edward .
JOURNAL OF UROLOGY, 2019, 201 (04) :E979-E979
[27]   Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression [J].
Zhao, Yicheng ;
Li, Wenliang .
ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (03) :253-259
[28]   Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation [J].
Mohammed Alshalalfa ;
Hatem Abou-Ouf ;
Elai Davicioni ;
R. Jeffrey Karnes ;
Reda Alhajj ;
Tarek A. Bismar .
Journal of Cancer Research and Clinical Oncology, 2021, 147 :2223-2231
[29]   Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation [J].
Alshalalfa, Mohammed ;
Abou-Ouf, Hatem ;
Davicioni, Elai ;
Karnes, R. Jeffrey ;
Alhajj, Reda ;
Bismar, Tarek A. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (08) :2223-2231
[30]   Neuroendocrine differentiation of prostate cancer and clinical outcome of Everolimus against neuroendocrine prostate cancer (NEPC) [J].
Shimomura, Tatsuya ;
Kurauti, Takashi ;
Sakanaka, Keigo ;
Suzuki, Hidenori ;
Goto, Hirokazu ;
Endo, Yasuhiko ;
Egawa, Shin .
INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 :359-359
12345